BEIJING, Sept. 9, 2013 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that it has successfully bid on a large-scale medical equipment procurement agreement valued at approximately $600,000 (RMB 3.7 million). The procurement agreement is with Beijing Kanglian Medicine Company and is part of the China Development Bank's ("CDB") Rural Medical and Healthcare Infrastructure Project in Guizhou and Hebei provinces.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical said, "In the past two years, Dehaier has successfully bid on several large-scale medical device procurement projects. We are pleased to offer high-quality Color Doppler Ultrasound machines and monitors to county hospitals and clinics in rural areas of China. The growth of our bulk procurement business depends on our strong and comprehensive sales and distribution platform. Moving forward, we will continue to focus on large projects like the Guizhou and Hebei province project, which offers us the opportunity to leverage this platform to drive revenues in a smaller number of large-scale projects."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, ten software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding bids for large-scale medical equipment procurement like those in Guizhou and Hebei province. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited Surie Liu +86 10-5166-0080 email@example.com Dehaier Medical Systems Limited Tina He +86 10-5166-0080 firstname.lastname@example.orgSource:Dehaier Medical Systems Limited